Skip to Main Content

Paper Details

Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date.
Vasc Health Risk Manag
8
2020
Author NameAffiliation
Xiaoming JiaBaylor College of Medicine
Mahmoud Al RifaiBaylor College of Medicine
Salim S ViraniBaylor College of Medicine
Salim S ViraniMichael E. DeBakey Veterans Affairs Medical Center Health Services Research and Development Center for Innovations
Salim S ViraniMichael E. DeBakey Veterans Affairs Medical Center
  • 1 - 5

Datasets